Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
Andre W. Bourgoyne, Bloodless Program Consultant at UChicago Medicine shared a post on LinkedIn:
“Anemia Management Is a Hospital Performance Strategy – Not Just a Lab Value
Preoperative anemia is one of the strongest predictors of surgical complications, longer hospital stays, and increased mortality.
Yet many hospitals still treat anemia reactively.
Forward-thinking institutions are shifting to Preoperative anemia management initiatives.
Why it matters:
- Fewer transfusions
- Lower complication rates
- Reduced ICU utilization
- Shorter length of stay
- Improved quality metrics
- Stronger financial performance
Optimizing hemoglobin before surgery with IV iron, B12, folate, nutrition, and appropriate EPO support doesn’t just protect patients – it protects institutional outcomes.
Anemia management is:
- Risk reduction
- Cost containment
- Outcome optimization
- Strategic differentiation
Hospitals that strengthen the blood before surgery strengthen their brand, their margins, and their mission.
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments